Literature DB >> 9212984

Electrophoretic patterns of urinary proteins of diabetics in the pre, early and overt nephropathy stages.

N Hiratsuka1, K Shiba, K Shinomura, S Hosaki, K Nishida, S Kobayashi.   

Abstract

Urinary proteins of patients with diabetes mellitus (DM) were analyzed using cellulose acetate membrane electrophoresis, to determine the clinical usefulness of fraction patterns of the proteins in detecting the group at high risk for diabetic nephropathy. We divided the protein patterns into 5 groups. Four groups (I, II, III, IV) were found in the healthy group and a newly classified group was termed group 0 and was characterized by a prominent albumin peak with a negligible or small globulin peak. The incidence of groups 0, I, II, III, and IV, was 36.6%, 13.3%, 18.7%, 10.7% and 22.7%, respectively. This distribution was clearly different from that of healthy subjects and the most characteristic feature of diabetics was that group 0 accounted for 36.6% of the total cases. Characteristic features of each group were examined from the aspect of laboratory and clinical findings. Urinary protein patterns were concluded to be useful not only to predict the high risk group for diabetic nephropathy in the preclinical stage but also to discriminate nephropathic types of glomerular or tubular origin. It is useful for clinicians to know the risk stage and prognosis for diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9212984     DOI: 10.1248/bpb.20.651

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  2 in total

1.  Semiquantitative analysis of urinary low protein levels using silver dot blot assay.

Authors:  K Matsuda; N Hiratsuka; Y Kurihara; K Shiba
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

2.  Analysis of urinary albumin, transferrin, N-acetyl-beta-D-glucosaminidase and beta2-microglobulin in patients with impaired glucose tolerance.

Authors:  N Hiratsuka; K Shiba; K Nishida; S Iizima; M Kimura; S Kobayashi
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.